Cover Image
市場調查報告書

代謝實驗解決方案的全球市場

Metabolic Testing Solutions

出版商 Global Industry Analysts, Inc. 商品編碼 346166
出版日期 內容資訊 英文 273 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
代謝實驗解決方案的全球市場 Metabolic Testing Solutions
出版日期: 2015年10月01日 內容資訊: 英文 273 Pages
簡介

本報告提供全球代謝實驗解決方案市場的相關調查、市場趨勢與到2020年的預測、各地區趨勢,及進入的主要企業簡介彙整。

第1章 簡介、調查方法、產品定義

第2章 摘要整理

  • 預測
    • 地區特有的文明病
    • 現在及未來分析
  • 產業概要
    • 氣體交換的生理學在正常代謝的維持中擔負指定的角色
    • 主要的最終用途與應用市場
    • 高齡化和作為標的症狀的發病率上升促進CPET系統的需求
    • 肥胖統計
    • 發展中國家有大幅可能性
    • 技術進步促進 CPET系統的需求、其他
  • 產品概要
    • 心肺運動檢驗
    • 代謝手推車
    • 心電圖
    • 代謝實驗技術
    • VO2 Max分析
    • RMR分析
    • 身體組成分析
  • 產品技術創新/引進
  • 近幾年的產業活動
  • 主要企業
    • AEI Technologies, Inc.
    • Bodystat Limited
    • CareFusion Corporation
    • CORTEX Biophysik GmbH
    • COSMED
    • GE Healthcare
    • Geratherm Medical AG
    • Hologic, Inc.
    • InBody Co., Ltd.
    • Iworx Systems, Inc.
    • Jawon Medical Co. Ltd.
    • KORR Medical Technologies, Inc.
    • Laica SpA
    • MGC Diagnostics Corporation
    • Microlife Medical Home Solutions, Inc.
    • Mindray Medical International Limited
    • Mortara Instrument, Inc.
    • 日本光電工業株式會社
    • Noraxon U.S.A., Inc.
    • Omron Healthcare, Inc.
    • Parvo Medics
    • Philips Healthcare
    • RJL Systems, Inc.
    • Schiller AG
    • seca GmbH & Co. KG.
    • Spacelabs Healthcare, Inc.
    • 株式會社tanita
    • Welch Allyn, Inc.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

競爭環境

目錄
Product Code: MCP-7976

This report analyzes the worldwide markets for Metabolic Testing Solutions in US$ Thousand by the following Product Segments: ECGs/EKGs, Metabolic Carts, CPET Systems, and Others. The market is also analyzed by the following Technologies: VO2 Max Analysis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 91 companies including many key and niche players such as -

AEI Technologies, Inc.
Bodystat Limited
CareFusion Corporation
CORTEX Biophysik GmbH
COSMED

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Product Segments
      • Cardio-pulmonary Exercise Testing
      • Metabolic Cart
      • Electrocardiogram
    • Product Technologies
      • VO2 Max Analysis
      • RMR Analysis
      • Body Composition Analysis

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Endemic Lifestyle Diseases - Cornerstone to Growth in Metabolic Testing Solutions
  • Current & Future Analysis

2. INDUSTRY OVERVIEW

  • Gas Exchange Physiology Plays a Defining Role in Maintaining Normal Body Metabolism
  • Major End-Use and Application Markets
    • Table 1: Global Metabolic Testing Solutions Market (2014): Percentage Share Breakdown of Value Sales by End-Use Site (includes corresponding Graph/Chart)
    • Table 2: Global Metabolic Testing Solutions Market (2014): Percentage Share Breakdown of Value Sales by Application (includes corresponding Graph/Chart)
  • Aging Population and Growing Incidence of Targeted Conditions Drive Demand for CPET Systems
    • Table 3: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 4: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
  • Obesity Statistics
    • Table 5: Overweight & Obese Individuals as % of Total Population by Geographic Region (includes corresponding Graph/Chart)
    • Table 6: Global Obesity Population by Country (2013 (includes corresponding Graph/Chart))
    • Table 7: Global Prevalence of Diabetic Mellitus (2014 & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region for Population in Age Group 20-79 Years (includes corresponding Graph/Chart)
  • Developing Economies Offer Significant Potential
  • Technological Advances Drive Demand for CPET Systems
  • Treadmill Testing Takes Precedence over Alternatives in CPET
  • Wider Adoption Potential Exists for CPET Systems in Clinical Application
    • Several Barriers Prevent Widespread Adoption of CPET in Clinical Settings
      • Overview of Select Barriers
      • Clinician Level Barriers
      • Institutional Barriers
      • Healthcare-Wide Barriers
      • Technology-Related Barriers
  • Metabolic Cart - The Gold Standard in Energy Expenditure Measurement
  • Major Indications of Metabolic Carts
  • Increasing Health and Fitness Consciousness Drives Demand for Body Composition Analysis Systems
  • BIA - The Most Preferred Body Composition Analysis Technique
    • Costs and Accuracy Benefits Drive Demand for BIA
  • Segmental Bioimpedance Gains Traction in Body Composition Analysis
  • Vector Analysis - A New Direction in Bioimpedance Data Analysis

3. PRODUCT OVERVIEW

  • Cardio-pulmonary Exercise Testing
    • Common Parameters analyzed with CPET
  • Metabolic Cart
  • Electrocardiogram
  • Metabolic Testing Technologies
  • VO2 Max Analysis
    • vVo2 Max
  • RMR Analysis
  • Body Composition Analysis

4. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Tanita Unveils Ironman Body Composition Monitors
  • Schiller Unveils CARDIOVIT FT-1
  • RJL Systems Unveils BC 4.0 BIA Software
  • seca and Coach Tom Shaw Unveil Premiere Body Composition Analyzer
  • BIOSPACE Unveils InBody 370 Body Composition Analyzer
  • seca Unveils seca mBCA 514 Body Composition Analyzer
  • Withings Unveils Smart Body Analyzer Scale

5. RECENT INDUSTRY ACTIVITY

  • Hill-Rom Takes Over Welch Allyn
  • Becton, Dickinson Takes Over CareFusion
  • MGC Diagnostics Takes Over MediSoft
  • KORR Partners with Biospace
  • MGC Diagnostics Partners with Frontera Strategies

6. FOCUS ON SELECT PLAYERS

  • AEI Technologies, Inc. (US)
  • Bodystat Limited (UK)
  • CareFusion Corporation (US)
  • CORTEX Biophysik GmbH (Germany)
  • COSMED (Italy)
  • GE Healthcare (UK)
  • Geratherm Medical AG (Germany)
  • Hologic, Inc. (US)
  • InBody Co., Ltd. (South Korea)
  • Iworx Systems, Inc. (US)
  • Jawon Medical Co. Ltd. (South Korea)
  • KORR Medical Technologies, Inc. (US)
  • Laica SpA (Italy)
  • MGC Diagnostics Corporation (US)
  • Microlife Medical Home Solutions, Inc. (US)
  • Mindray Medical International Limited (China)
  • Mortara Instrument, Inc. (US)
  • Nihon Kohden Corporation (Japan)
  • Noraxon U.S.A., Inc. (US)
  • Omron Healthcare, Inc. (US)
  • Parvo Medics (US)
  • Philips Healthcare (Netherlands)
  • RJL Systems, Inc. (US)
  • Schiller AG (Switzerland)
  • seca GmbH & Co. KG. (Germany)
  • Spacelabs Healthcare, Inc. (US)
  • Tanita Corporation (Japan)
  • Welch Allyn, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Market by Product Segment
    • Table 11: World Recent Past, Current & Future Analysis for ECGs/EKGs in Metabolic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for ECGs/EKGs in Metabolic Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for ECGs/EKGs in Metabolic Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 14: World Recent Past, Current & Future Analysis for Metabolic Carts by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Metabolic Carts by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 16: World 14-Year Perspective for Metabolic Carts by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 17: World Recent Past, Current & Future Analysis for CPET Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 18: World Historic Review for CPET Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 19: World 14-Year Perspective for CPET Systems by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 20: World Recent Past, Current & Future Analysis for Other Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 21: World Historic Review for Other Metabolic Testing Solutions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 22: World 14-Year Perspective for Other Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Market Analysis by Technology
    • Table 23: World Recent Past, Current & Future Analysis for VO2 Max Analysis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 24: World Historic Review for VO2 Max Analysis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 25: World 14-Year Perspective for VO2 Max Analysis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 26: World Recent Past, Current & Future Analysis for Other Metabolic Testing Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 27: World Historic Review for Other Metabolic Testing Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 28: World 14-Year Perspective for Other Metabolic Testing Technologies by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Growing Menace of Obesity provides a Strong Case for Metabolic Testing Solutions
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 29: US Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: US Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 31: US 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 32: US Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 33: US Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 34: US 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 35: Canadian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Canadian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 37: Canadian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 38: Canadian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 39: Canadian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 40: Canadian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 41: Japanese Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: Japanese Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 43: Japanese 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 44: Japanese Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Japanese Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: Japanese 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • Market Analysis
    • Table 47: European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: European Historic Review for Metabolic Testing Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 49: European 14-Year Perspective for Metabolic Testing Solutions by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 50: European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 51: European Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 52: European 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 53: European Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 54: European Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 55: European 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launch
  • B. Market Analytics
    • Table 56: French Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 57: French Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 58: French 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 59: French Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 60: French Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 61: French 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
    • Product Launches
  • B. Market Analytics
    • Table 62: German Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 63: German Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 64: German 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 65: German Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 66: German Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 67: German 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 68: Italian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 69: Italian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 70: Italian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 71: Italian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 72: Italian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 73: Italian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 74: UK Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 75: UK Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 76: UK 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 77: UK Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 78: UK Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 79: UK 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 80: Spanish Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 81: Spanish Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 82: Spanish 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 83: Spanish Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: Spanish Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 85: Spanish 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 86: Russian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 87: Russian Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 88: Russian 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 89: Russian Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Russian Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: Russian 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Product Launches
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 93: Rest of Europe Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 94: Rest of Europe 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 96: Rest of Europe Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 97: Rest of Europe 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Increasing Prevalence of Cardiopulmonary Diseases Drives Demand for CPET Systems
    • Key Players
  • B. Market Analytics
    • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 99: Asia-Pacific Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 100: Asia-Pacific 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Asia-Pacific Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 103: Asia-Pacific 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 104: Latin American Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 105: Latin American Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 106: Latin American 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/ EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 107: Latin American Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 108: Latin American Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 109: Latin American 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 110: Rest of World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 111: Rest of World Historic Review for Metabolic Testing Solutions by Product Segment - ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 112: Rest of World 14-Year Perspective for Metabolic Testing Solutions by Product Segment - Percentage Breakdown of Dollar Sales for ECGs/EKGs, Metabolic Carts, CPET Systems and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 113: Rest of World Recent Past, Current & Future Analysis for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 114: Rest of World Historic Review for Metabolic Testing Solutions by Technology - VO2 Max Analysis and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 115: Rest of World 14-Year Perspective for Metabolic Testing Solutions by Technology - Percentage Breakdown of Dollar Sales for VO2 Max Analysis and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top